What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.85%Below 5Y avg (1.98%)
Annual Rate
CNY 1.60Paid semi-annual
Payout Ratio
86.1%High
Payback Period
78.6 yr
Last Ex-Dividend
Jul 8, 2026
The reported statements, read against the company's own industry.
What stands out
Earnings significantly exceed cash generation
Financials view
Market Capitalization
9.67BCNY
1.44B · vs all stocks (USD)
Updated Aug 21, 2026
Trailing P/E
42.67x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Revenue (TTM)
1.30BCNY
194.02M · vs all stocks (USD)
Updated Aug 21, 2026
Profit Margin
12.93%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Beta
1.47x
vs all stocks
Updated Aug 21, 2026
52-Week Change
136.57%
vs all stocks
Updated Aug 21, 2026
Forward Annual Dividend Yield
1.85%
vs all stocks
Updated Aug 21, 2026
Market Capitalization
9.67BCNY
1.44B · vs all stocks (USD)
Updated Aug 21, 2026
Enterprise Value
7.60BCNY
1.13B · vs all stocks (USD)
Updated Aug 21, 2026
Trailing P/E
42.67x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Forward P/E
30.92x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Price to Sales (TTM)
6.29x
vs Scientific & Technical Instruments peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 7.41×.Updated Aug 21, 2026
Price to Book (MRQ)
6.48x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Enterprise to Revenue
5.82x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Enterprise to EBITDA
35.29x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 37.08×.Updated Aug 21, 2026
Gross Margin
46.49%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 43.55%.Updated Aug 21, 2026
Profit Margin
12.93%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Operating Margin
22.93%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Return on Assets (TTM)
6.10%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Return on Equity (TTM)
12.27%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Revenue (TTM)
1.30BCNY
194.02M · vs all stocks (USD)
Updated Aug 21, 2026
Revenue per Share (TTM)
11.70CNYUpdated Aug 21, 2026
Quarterly Revenue Growth
27.00%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Gross Profit (TTM)
568.24MCNY
84.50M · vs all stocks (USD)
Updated Aug 21, 2026
EBITDA (TTM)
204.86MCNY
30.46M · vs all stocks (USD)
Updated Aug 21, 2026
Net Income (TTM)
168.68MCNY
25.08M · vs all stocks (USD)
Updated Aug 21, 2026
Quarterly Earnings Growth (YoY)
31.70%
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Operating Cash Flow (TTM)
1.67MCNY
247.66K · vs all stocks (USD)
Updated Aug 21, 2026
Levered Free Cash Flow (TTM)
-305.68MCNY
-45.46M · vs all stocks (USD)
Updated Aug 21, 2026
Forward Annual Dividend Rate
1.60CNYUpdated Aug 21, 2026
Forward Annual Dividend Yield
1.85%
vs all stocks
Updated Aug 21, 2026
Trailing Annual Dividend Rate
1.10CNYUpdated Aug 21, 2026
Trailing Annual Dividend Yield
1.27%
vs all stocks
Updated Aug 21, 2026
5-Year Average Dividend Yield
1.98%
vs all stocks
Updated Aug 21, 2026
Payout Ratio
86.09%
vs Scientific & Technical Instruments peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 63.95%.Updated Aug 21, 2026
Minority Interest (Equity)
-378.87KCNYFY2025 · Dec 31, 2025
Revenue
1.22BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
693.87MCNYFY2025 · Dec 31, 2025
Gross Profit
526.89MCNYFY2025 · Dec 31, 2025
Operating Income
150.96MCNY
22.45M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
146.55MCNYFY2025 · Dec 31, 2025
Income Tax Expense
4.24MCNYFY2025 · Dec 31, 2025
Net Income
142.31MCNYFY2025 · Dec 31, 2025
EBIT
149.92MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
214.67MCNYFY2025 · Dec 31, 2025
Research & Development
145.93MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
82.05MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
11.94MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
5.45MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
3.38MCNYFY2025 · Dec 31, 2025
EPS (Basic)
1.36CNYFY2025 · Dec 31, 2025
EPS (Diluted)
1.36CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
111.20MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
111.20MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
142.31MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
8.92MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
-20.35MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-104.66MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
71.90MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
142.31MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
-1.35MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-34.76MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-126.55MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-84.32MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-30.00MCNYFY2025 · Dec 31, 2025
Sale of Investments
165.62KCNYFY2025 · Dec 31, 2025
Other Investing Activity
102.83MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-11.32MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
60.40MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-92.10MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-146.57MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-10.01MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-188.28MCNYFY2025 · Dec 31, 2025
Shares Outstanding
111.77MSharesUpdated Aug 21, 2026
Float Shares
52.26MSharesUpdated Aug 21, 2026
% Held by Insiders
63.90%
vs all stocks
Updated Aug 21, 2026
% Held by Institutions
3.05%
vs all stocks
Updated Aug 21, 2026
Total Cash (MRQ)
122.05MCNY
18.15M · vs all stocks (USD)
Updated Aug 21, 2026
Total Cash per Share (MRQ)
1.09CNYUpdated Aug 21, 2026
Total Debt (MRQ)
128.81MCNY
19.16M · vs all stocks (USD)
Updated Aug 21, 2026
Total Debt to Equity (MRQ)
0.0962x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Current Ratio (MRQ)
2.80x
vs Scientific & Technical Instruments peers
Updated Aug 21, 2026
Book Value per Share (MRQ)
11.32CNYUpdated Aug 21, 2026
Total Assets
1.66BCNY
246.47M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
944.28MCNYFY2025 · Dec 31, 2025
Total Liabilities
392.38MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
713.10MCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
43.43MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
348.96MCNYFY2025 · Dec 31, 2025
Cash
70.80MCNYFY2025 · Dec 31, 2025
Cash Equivalents
3.28MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
74.09MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
10.00MCNYFY2025 · Dec 31, 2025
Accounts Receivable
164.25MCNYFY2025 · Dec 31, 2025
Inventory
480.38MCNYFY2025 · Dec 31, 2025
Accounts Payable
176.92MCNYFY2025 · Dec 31, 2025
Short-term Debt
57.77MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
5.46MCNYFY2025 · Dec 31, 2025
Long-term Debt
40.34MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
111.77MCNYFY2025 · Dec 31, 2025
Retained Earnings
481.17MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
1.27BCNY
188.12M · vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
30.41CNYUpdated Aug 21, 2026
52-Week High
120.00CNYUpdated Aug 21, 2026
52-Week Change
136.57%
vs all stocks
Updated Aug 21, 2026
Beta
1.47x
vs all stocks
Updated Aug 21, 2026
50-Day MA
80.11CNYUpdated Aug 21, 2026
200-Day MA
58.89CNYUpdated Aug 21, 2026
Avg 10-Day Volume
4.13MSharesUpdated Aug 21, 2026
Avg 30-Day Volume
4.43MSharesUpdated Aug 21, 2026
Diluted EPS (TTM)
1.72CNYUpdated Aug 21, 2026
4 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
Minimal Tax and Interest Drag
Almost nothing is lost between its operating profit and its net income.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Minimal Tax and Interest DragMulti-Year Revenue, Profit, And Income GrowthUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
Minimal Tax and Interest DragMulti-Year Revenue, Profit, And Income GrowthUlcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated